{"id":"W4399654151","doi":"10.1016/j.jtct.2024.06.010","title":"Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Legend Biotech; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Health Resources and Services Administration; Syndax Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Biorepository; Hematopoietic cell; Medicine; Bone marrow transplant; Intensive care medicine; Bone transplantation; Haematopoiesis; Hematologic Neoplasms; Bone marrow; Bone marrow transplantation; Immunology; Internal medicine; Transplantation; Stem cell; Bioinformatics; Surgery; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05629757,0.00105965,0.001392779,0.009300817,0.00182467,0.01016882,0.004394762,0.001437381,0.03705719],"category_scores_gemma":[0.1199416,0.0009480264,0.001281556,0.006254973,0.001608851,0.007989348,0.01374292,0.004707191,0.01131973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003366715,"about_ca_system_score_gemma":0.02550022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008646552,"about_ca_topic_score_gemma":0.01543543,"domain_scores_codex":[0.9620509,0.02177019,0.004185345,0.002978727,0.006829284,0.002185582],"domain_scores_gemma":[0.8205631,0.05890389,0.02347866,0.03556514,0.03558306,0.02590621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00091559,0.002195502,0.1861296,0.001041981,0.0004811734,0.000608532,0.00130122,0.004229798,0.003636198,0.01573769,0.2770943,0.5066284],"study_design_scores_gemma":[0.0009889746,0.001226119,0.1464612,0.004416561,0.0007409221,0.001242835,0.005312324,0.01401491,0.01304523,0.06006858,0.7519849,0.0004973457],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1370545,0.01541856,0.2387798,0.3296133,0.009067832,0.008399377,0.06599259,0.01580391,0.1798701],"genre_scores_gemma":[0.5468851,0.01129315,0.2535011,0.06790213,0.009531437,0.006938499,0.07650579,0.004982475,0.02246039],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05629757,"threshold_uncertainty_score":0.2977335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03881202354631987,"score_gpt":0.3062114087726352,"score_spread":0.2673993852263153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}